|
Characteristic
|
All patients (n = 133)
|
|---|
|
Age (days)
|
36.56 ± 26.78
|
|
≤28 days
|
50 (37.6 %)
|
|
>28 days and ≤ 90 days
|
83 (62.4 %)
|
|
Gender
|
|
Male
|
89 (66.9 %)
|
|
Female
|
44 (33.1 %)
|
|
Weight (kg)
|
3.89 ± 0.91
|
|
RACHS-1
|
|
Score-1
|
4 (3.0 %)
|
|
Score-2
|
46 (34.6 %)
|
|
Score-3
|
44 (33.1 %)
|
|
Score-4
|
38 (28.6 %)
|
|
Score-5
|
1 (0.7 %)
|
|
Score-6
|
0(0 %)
|
|
Type of Surgery
|
|
ASD
|
2 (1.5 %)
|
|
VSD
|
12 (9.0 %)
|
|
VSD + ASD
|
50 (37.6 %)
|
|
COA/IAA
|
15(11.3 %)
|
|
TAPVC
|
21(15.8 %)
|
|
TGA
|
19 (14.3 %)
|
|
PA-VSD
|
3 (2.2 %)
|
|
DORV
|
2 (1.5 %)
|
|
Other
|
9 (6.8 %)
|
|
Operative factors
|
|
CPB time (min)
|
114.23 ± 81.98
|
|
ACC time (min)
|
46.03 ± 21.59
|
|
ICU mortality
|
13 (9.8 %)
|
|
Preoperative serum albumin (g/L)
|
38.23 ± 4.87
|
|
Preoperative thyroid function
|
|
FT3 (pmol/L)
|
4.99 ± 1.54
|
|
FT4 (pmol/L)
|
21.28 ± 5.82
|
|
TT3 (nmol/L)
|
1.87 ± 0.56
|
|
TT4 (nmol/L)
|
120.25 ± 34.61
|
|
TSH (µIU/ml)
|
5.72 ± 5.95
|
- RACHS-1 Risk Adjustment in Congenital Heart Surgery-1, ASD atrial septal defect, VSD ventricular septal defect, COA coarctation of aorta, IAA interrupter aortic arch, TAPVC total anomalous pulmonary venous connection, TGA transposition of the great arteries, PA pulmonary atresia, DORV double outlet right ventricular, CPB cardiopulmonary bypass, ACC aortic cross-clamping, FT3 free triiodothyronine, FT4 free thyroxin, TT3 total triiodothyronine, TT4 total thyroxin, TSH thyroid stimulating hormone
